NEWS
A milestone has been reached
After an intensive and targeted work, the cell line development of our lead drug candidate SOL-116 has been finalized. Now the production optimization and scale up has been initiated and that will provide access of [...]
Professor Anders Fasth joins the scientific advisory board
Press release November 29, 2019 […]
Pharma Outsourcing 2019
“How we selected our CMO partner for cell line and production development of Lipum´s lead candidate drug SOL-116” […]
Lipum in preparation for Bio-Europe
– Our goal is to meet with investors interested in our next financing round, says our CEO Einar Ponten in preparation for Bio-Europe in Hamburg, 11-13 November. […]
BioStock Life Science Summit
Life Science industry leaders, financing experts and qualified investors gather in Lund. Welcome to meet us at Biostock Life Science Summit, october 23th-24th. […]
Lipum participates in investment and partnering meeting
Today, our COO, Pernilla Abrahamsson, is traveling to Paris to participate at French-Swedish Life Science Days 2019. The goal of the conference is to establish new contacts and identify business and collaboration opportunities. The conference [...]
Lipum to Basel for one-to-one meetings
- We are looking forward to one-to-one meetings in Basel, among the largest biopharma hubs in Europe, says CEO Einar Pontén when Lipum is preparing to participate at the 19th Annual Biotech in Europe Forum [...]
Lipum attends the largest Nordic Partnering Conference
- This is the right arena for Lipum, says Einar Pontén. It gives us an opportunity to meet people and inform about our progress and long-term plan. Lipum will participate September 10-12th at Nordic Life [...]
BioStock’s article series on autoimmune disease: Drug development for RA and MS
Therapies for autoimmune diseases are available but do not work for all patients, and when they do, side effects can be severe. There is a strong need for new therapies and therefore there is a [...]
INVESTOR RELATIONS
